Rank
91
Rite Aid
A pedestrian walks past a Rite Aid Corp. store in New York, U.S., on Wednesday, Dec. 14, 2016. Photographer: Victor J. Blue/Bloomberg via Getty ImagesVictor J. Blue — Bloomberg via Getty Images
- Previous Rank107
- Revenues ($M)30737
- Revenue Percent Change15.9
- Profits ($M)165.5
- Profits Percent Change-92.2
- Assets ($M)11277
- Employees70580
- Market Value — as of March 31, 2017 ($M)4473
The proposed $9.4 billion merger between Rite Aid and Walgreens faces increasing scrutiny from the Federal Trade Commission. Rite Aid CEO John Standley has criticized what he says is a drawn-out regulatory process but has also admitted that the uncertainty around the deal is taking a hit on the pharmacy and drug store chain's business. In a recent letter to employees, Standley seemed to imply that Rite Aid is mulling how to proceed if the deal falls through.
Company Info
| CEO | John T. Standley |
| CEO Title | Chairman & Chief Executive Officer |
| Sector | Food & Drug Stores |
| Industry | Food and Drug Stores |
| HQ Location | Camp Hill, PA |
| Website | www.riteaid.com |
| Years on Fortune 500 List | 23 |
| Employees | 70,580 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $30,737 |
| Profits ($M) | $165.5 |
| Assets ($M) | $11,277 |
| Total Stockholder Equity ($M) | $581 |
| Market Value — as of March 31, 2017 ($M) | $4,473 |
Profit Ratios
| Profit as % of Revenues | 0.5% |
| Profits as % of Assets | 1.5% |
| Profits as % of Stockholder Equity | 28.5% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 0 |
| EPS % Change (from 2015) | -92.3% |
| EPS % Change (5 year annual rate) | - |
| EPS % Change (10 year annual rate) | -21.9% |
Total Return
| Total Return to Investors (2016) | 5.1% |
| Total Return to Investors (5 year, annualized) | 45.6% |
| Total Return to Investors (10 year, annualized) | 4.2% |